New York Life Investment Management’s Palantir PLTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.4M Buy
320,224
+2,895
+0.9% +$395K 0.26% 76
2026
Q1
$46.4M Buy
317,329
+4,107
+1% +$628K 0.39% 48
2025
Q4
$55.7M Buy
313,222
+4,691
+2% +$849K 0.48% 34
2025
Q3
$56.3M Buy
308,531
+19,200
+7% +$3.11M 0.49% 35
2025
Q2
$39.4M Buy
289,331
+15,002
+5% +$1.76M 0.37% 50
2025
Q1
$23.2M Sell
274,329
-691
-0.3% -$60.7K 0.24% 86
2024
Q4
$20.8M Buy
275,020
+154,139
+128% +$8.98M 0.2% 96
2024
Q3
$4.5M Buy
+120,881
New +$3.71M 0.04% 377

Other funds holding PLTR

New York Life Investment Management's PLTR Position: Q2 2026 in Review

New York Life Investment Management increased its Palantir (PLTR) stake by 0.91% in Q2 2026, buying an estimated $395K and bringing the position to 320,224 shares worth $37.4M. The position accounts for 0.26% of the portfolio, ranked #76.

New York Life Investment Management first reported a position in PLTR in Q3 2024 and has held it in 8 quarters since. The position peaked at $56.3M in Q3 2025. 2,838 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

  • New York Life Investment Management held 320,224 shares of Palantir worth $37.4M as of Q2 2026.
  • New York Life Investment Management bought 2,895 Palantir shares in Q2 2026, an estimated $395K.
  • Palantir made up 0.26% of New York Life Investment Management's portfolio in Q2 2026, its #76 holding.
  • New York Life Investment Management first reported a position in Palantir in Q3 2024 and has held it in 8 quarters since.
  • New York Life Investment Management's Palantir position peaked at $56.3M in Q3 2025.
  • 2,838 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.